Regulatory and ClinicalOrphan Drug DesignationAug 13, 2026 · 11:44am ET
BYSIBeyondSpring Inc.
BeyondSpring's SEED Therapeutics Receives FDA Orphan Drug Designation for Neuroblastoma Treatment
The designation was granted for ST-01156, a drug targeting neuroblastoma.
